Is Botox Bad for You? What the Boxed Warning Says, and Who It Is About
Reviewed for medical accuracy against our Medical Review Board · Last updated 5 September 2026
Part of Botox Guides and Basics
It carries a boxed warning, which is the strongest warning the FDA issues. It also has one of the longest safety records of any drug used cosmetically. Both of those are true and most answers to this question pick one and stop.
1. The boxed warning, in full
Start with the thing clinics tend not to mention. Every botulinum toxin product carries a boxed warning, and here is what it says.
Postmarketing reports indicate that the effects may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. The label names them: asthenia, generalised muscle weakness, double vision, drooping eyelid, difficulty swallowing, voice changes, slurred speech, urinary incontinence and breathing difficulties. These have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening, and there have been reports of death.
That is not softened here because it should not be. It is the actual text.
2. Who that warning is actually about
Read the next two sentences of the same warning, because they are the ones that place it.
The risk of symptoms is probably greatest in children treated for spasticity, and symptoms can also occur in adults treated for spasticity and other conditions, particularly in patients with an underlying condition that predisposes them. The label adds that cases have been reported at doses comparable to those used for cervical dystonia and spasticity, and at lower doses.
Now the arithmetic that the warning does not do for you:
| Use | Dose |
|---|---|
| Frown lines, cosmetic | 20 Units |
| Forehead lines with frown lines | 40 Units |
| Chronic migraine | 155 Units |
| Cervical dystonia and limb spasticity | Several hundred Units |
So the population the boxed warning centres on is being dosed at ten to twenty times a cosmetic treatment, often into the neck or limbs, frequently with a neuromuscular condition already present. That does not make the warning irrelevant to you. It means the risk it describes is not evenly distributed, and the honest framing is that you are at the low end of a real risk rather than outside it. Our medical uses page covers the high end.
3. What actually happens at cosmetic doses
The adverse reactions reported in the cosmetic trials, from section 6.1:
- Frown lines: eyelid drooping in 3%.
- Crow's feet: eyelid swelling in 1%.
- Forehead lines: headache in 9%, and brow drooping.
Those are the honest numbers. A drooping eyelid at three in a hundred is not rare enough to be dismissed, and it is also temporary, because it resolves as the effect wears off. Our page on things going wrong covers what each looks like and what can and cannot be corrected while you wait.
Notice what is not on that list: organ damage, cancer risk, anything cumulative. Those do not appear because they have not been established, not because the label is being polite.
4. It does not accumulate, and it reverses
The mechanism matters here more than any reassurance. Section 12.1 describes the drug blocking the release of acetylcholine at the nerve terminal by cleaving a protein called SNAP-25, producing partial chemical denervation of the injected muscle.
Then it describes the recovery: axonal sprouting may occur, new receptors may develop, and reinnervation may occur, slowly reversing the denervation. That is why the effect wears off, and it is also the answer to whether the drug builds up. It does not sit in tissue waiting. The nerve rebuilds and you return to baseline.
Muscle atrophy from reduced use is real and is expected. It is also the same process as any muscle used less, and it reverses when treatment stops. It is the mechanism behind masseter slimming rather than a hidden harm. What Botox is actually made of is covered here.
5. The immunity worry, and what the data shows
The specific fear is that repeated use trains your body to neutralise it. It is measurable, and it has been measured.
- Botox Cosmetic: 916 subjects across three crow's feet trials. 1.5% developed binding antibodies, none developed neutralizing antibodies.
- Dysport, frown lines: 1,554 subjects across up to nine treatment cycles. None developed neutralizing antibodies.
- Xeomin: across 2,649 patients, 0.3% plus a further 0.2%, and the label adds that no patient showed a secondary loss of response because of them.
At medical doses the rates rise to a few percent, which is the same pattern as everything else on this page: the variable is dose. Section 9 of our duration guide goes through it in full.
6. What genuinely is not known
Three honest gaps, because a page that claims none is not being straight with you.
- Pregnancy. There are no studies and no adequate postmarketing data on developmental risk in pregnant women. Animal studies showed reduced fetal weight and skeletal ossification at clinically relevant doses. For breastfeeding there are no data at all. This is the clearest "nobody knows" in the label.
- Decades of cosmetic use. The longest published cosmetic repeat-dosing dataset runs to nine treatment cycles, a little over two years. Anyone telling you thirty years of cosmetic use is proven safe is going past what exists.
- Off-label areas. Only four cosmetic areas have approved doses. For everything else the dose is convention, and the safety data is whatever your injector has seen.
7. So is it bad for you
The defensible answer, stated as precisely as the evidence allows:
At approved cosmetic doses, in a healthy adult, injected by someone qualified, the documented risks are local, temporary and quantified, and the mechanism is reversible. The serious harm in the boxed warning is real and is concentrated in a different population at ten to twenty times the dose.
What moves you toward the risky end is not the drug. It is dose, an underlying neuromuscular condition, off-label areas where nobody has established a dose, and an injector who did not ask about any of it. Every one of those is a decision rather than a property of the molecule, which is why our pre-treatment guide spends more space on who should not have it than on who should.
If you want one question to carry into a consultation: ask what dose, in units, and why that number. Someone who answers it easily is managing the variable that this entire page turns on.
Frequently asked questions
Is Botox bad for you?
Does Botox have a black box warning?
Does Botox build up in your body?
Is Botox toxic long term?
Can Botox spread to other parts of the body?
Is Botox safe during pregnancy?
Who is most at risk from Botox?
Sources
Every figure on this page was read from the documents below rather than from a clinic or a manufacturer's marketing. They open in a new tab so you can check any claim here against its source.
- BOTOX Cosmetic (onabotulinumtoxinA) for injection, full prescribing information, US National Library of Medicine, DailyMed
- BOTOX (onabotulinumtoxinA) prescribing information, therapeutic indications, US National Library of Medicine, DailyMed
- Dysport (abobotulinumtoxinA) for injection, full prescribing information, US National Library of Medicine, DailyMed
- Xeomin (incobotulinumtoxinA) for injection, full prescribing information, US National Library of Medicine, DailyMed
Know the count before the quote. The unit count is half the bill, and a low per-unit rate recovered by a high unit count is the commonest way a deal is not one. How to tell.
Deciding which area, not how many units? Botox by facial area covers what each zone actually achieves, which four are FDA approved, and the things Botox cannot fix at all.
